Literature DB >> 3119973

The regulation of nursing homes: a comparative perspective.

P Day1, R Klein.   

Abstract

Britain and the United States alike face the question of how best to protect the growing and vulnerable population of nursing home residents through State regulation of private institutions. Despite marked differences in scale, organization, and financing between the two nations, there are striking similarities in the problems encountered and in styles of enforcement adopted in response. Analysis of the regulatory systems in practice shows a convergence in the regulatory process despite the dissimilarities between formal regulatory models. Both systems are responding--however imperfectly--to the social environment of nursing home care. Future regulatory policy will have to encompass formal and informal, legal and social control.

Entities:  

Mesh:

Year:  1987        PMID: 3119973

Source DB:  PubMed          Journal:  Milbank Q        ISSN: 0887-378X            Impact factor:   4.911


  5 in total

1.  Regulating nursing homes: Caring for older people in the private sector in England.

Authors:  S H Kerrison; A M Pollock
Journal:  BMJ       Date:  2001-09-08

Review 2.  The rise of regulation in the NHS.

Authors:  Kieran Walshe
Journal:  BMJ       Date:  2002-04-20

3.  State "technical assistance programs" for nursing home quality improvement: variations and potential implications.

Authors:  Yue Li; William D Spector; Laurent G Glance; Dana B Mukamel
Journal:  J Aging Soc Policy       Date:  2012

4.  Supervision of care networks for frail community dwelling adults aged 75 years and older: protocol of a mixed methods study.

Authors:  Didi Verver; Hanneke Merten; Paul Robben; Cordula Wagner
Journal:  BMJ Open       Date:  2015-08-25       Impact factor: 2.692

5.  Experimental studies to improve the reliability and validity of regulatory judgments on health care in the Netherlands: a randomized controlled trial and before and after case study.

Authors:  Saskia M Tuijn; Huub van den Bergh; Paul Robben; Frans Janssens
Journal:  J Eval Clin Pract       Date:  2014-05-12       Impact factor: 2.431

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.